Lexeo Therapeutics, Inc. (LXEO) Free cash flow 2022–2025
Lexeo Therapeutics, Inc. (LXEO) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$99.0MFY2025 · since FY2022: -$55.2M → -$99.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$99.0M | -21.2% |
| FY2024 | -$81.6M | -36.9% |
| FY2023 | -$59.6M | -7.9% |
| FY2022 | -$55.2M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice